Detection of stable N-terminal protachykinin A immunoreactivity in human plasma and cerebrospinal fluid

Peptides

Volumn 29, Issue 7, 2008, Pages 1201-1206

  Ernst, Andrea ^a   Suhr, Jennifer ^a   Köhrle, Josef ^b   Bergmann, Andreas ^a,c  

^a SPHINGOTEC GMBH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BRAHMS AG   (Germany)

Author keywords

CSF; Immunoassay; Neuropeptide; NT PTA; Protachykinin A; Substance P; Tachykinin A

Indexed keywords

ANTIBODY; EDETIC ACID; MESSENGER RNA; NEUROPEPTIDE; PROTACHYKININ A; SUBSTANCE P;

AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CIRCULATION; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RNA SPLICING; STOICHIOMETRY;

AMINO ACID SEQUENCE; CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; EDETIC ACID; HUMANS; IMMUNOASSAY; MOLECULAR SEQUENCE DATA; PROTEIN PRECURSORS; TACHYKININS; TIME FACTORS;

EID: 44649159556     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.02.006     Document Type: Article

References (42)

1. Almeida T.A., Rojo J., Nieto P.M., Hernandez M., Martin J.D., and Candenas M.L. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 11 (2004) 2045-2081
2. Anichini M., Cesaretti S., Lepori M., Maddali Bongi S., Maresca M., and Zoppi M. Substance P in the serum of patients with rheumatoid arthritis. Rev Rhum (Engl Ed) 64 (1997) 18-21
3. Beaujouan J.C., Torrens Y., Saffroy M., Kemel M.L., and Glowinski J. A 25-year adventure in the field of tachykinins. Peptides 25 (2004) 339-357
4. Beer S., Weighardt H., Emmanuilidis K., Harzenetter M., Matevossian E., Heidecke C.D., et al. Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 30 (2001) 1794-1798
5. Blumberg S., Teichberg V.I., Charli J.L., Hersh L.B., and Mc Kelvy J.F. Cleavage of substance P to an N-terminal tetrapeptide and a C-terminal heptapeptide by a postproline cleaving enzyme from bovine brain. Brain Res 192 (1980) 477-486
6. Bost K.L. Tachykinin-modulated anti-viral responses. Front Biosci 9 (2004) 1994-1998
7. Bruno G., Tega F., Bruno A., Graf U., Corelli F., Mofetta R., et al. The role of substance P in cerebral ischemia. Int J Immunopathol Pharmacol 16 (2003) 67-72
8. Cailes J., Winter S., du Bois R.M., and Evans T.W. Defective endothelially mediated pulmonary vasodilation in systemic sclerosis. Chest 114 (1998) 178-184
9. Conlon J.M., and Sheehan L. Conversion of substance P to C-terminal fragments in human plasma. Regul Pep 7 (1983) 335-345
10. de Ceballos M.L., Fernandez A., Jenner P., and Marsden C.D. Parallel alterations in Met-enkephalin and substance P levels in medial globus pallidus in Parkinson's disease patients. Neurosci Lett 160 (1992) 163-166
11. Ernst A., Köhrle J., and Bergmann A. Proenkephalin A 119-159, a stable proenkephalin A precursor fragment identified in human circulation. Peptides 27 (2006) 1835-1840
12. Evangelista S. Involvement of tachykinins in intestinal inflammation. Cur Pharmaceut Design 7 (2001) 19-30
13. Harmar A.J., Hyde V., and Chapman K. Identification and cDNA sequence of delta-preprotachykinin, a fourth splicing variant of the rat substance P precursor. FEBS Lett 275 (1990) 22-24
14. Harrison S., and Geppetti P. Substance P. Int J Biochem Cell Biol 33 (2001) 555-576
15. Heymann E., and Mentlein R. Liver dipeptidyl aminopeptidase IV hydrolyzes substance P. FEBS Lett 91 (1978) 360-364
16. Ho W.Z., Lai J.P., Zhu X.H., Uvaydova M., and Douglas S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 159 (1997) 5654-5660
17. Joyce T.J., Yood R.A., and Carraway R.E. Quantitation of substance-P and its metabolites in plasma and synovial fluid from patients with arthritis. J Clin Endocrinol Metabolism 77 (1993) 632-637
18. Kage R., Thim L., Creutzfeldt W., and Conlon M. Post-translational processing of preprotachykinins-isolation of Protachykinin-(1-37)-peptide from human adrenal-medullary phaeochromocytoma tissue. Biochem J 253 (1988) 203-207
19. Kawaguchi Y., Hoshimaru M., Nawa H., and Nakanishi S. Sequence analysis of cloned cDNA for rat substance P precursor: existence of a third substance P precursor. Biochem Biophys Res Comm 139 (1986) 1040-1046
20. Killingsworth R.C., Shore S.A., Alessandrini F., Dey R.D., and Paulauskis J.D. Rat alveolar macrophages express preprotachykinin gene-I mRNA-encoding tachykinins. Am J Physiol 273 (1997) L1073-L1081
21. Lai J.P., Douglas S.P., and Ho W.Z. Human lymphocytes express substance P and its receptor. J Neuroimmunol 86 (1998) 80-86
22. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 45 (1995) 1-98
23. Marriott I. The role of tachykinins in central nervous system inflammatory responses. Front Biosci 9 (2004) 2153-2165
24. Matsuishi T., Nagamitsu S., Shoji H., Itoh M., Takashima S., Iwaki T., et al. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. J Neural Trans 106 (1999) 943-948
25. McArthur J., Hill J., Peach M.J., Dodd P.H., Bennett E.J., and Holden J. Cerebrospinal fluid and serum concentrations of beta-trace protein during pregnancy. Anaesthesia 60 (2005) 163-167
26. Nawa H., Kotani H., and Nakanishi S. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature 312 (1984) 729-734
27. Nelson D.A., and Bost K.L. Non-neuronal mammalian tachykinin expression. Front Biosci 9 (2004) 2166-2176
28. Nicoll R.A., Schenker C., and Leeman S.E. Substance P as a neurotransmitter candidate. Ann Rev Neurosci 3 (1980) 227-268
29. O'Connor T.M., O'Connell J., O'Brien D.I., Goode T., Bredin C.P., and Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 201 (2004) 167-180
30. Otsuka M., and Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 667 (1993) 229-308
31. Pascual D.W., and Bost K.L. Substance P production by macrophage cell lines: a possible autocrine function for this Neuropeptide. Immunology 71 (1990) 52-56
32. Pascual D.W. The role of tachykinins on bacterial infections. Front Biosci 9 (2004) 3209-3217
33. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., and Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci 74 (2004) 1445-1463
34. Richfield E.K., Vonsattel J.P., Mac Donald M.E., Sun Z., Deng Y.P., and Reiner A. Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease. Movement Disord 17 (2002) 327-332
35. Roesler N., Wichert I., and Jellinger K.A. Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer's disease patients. Neurosci Lett 299 (2001) 117-120
36. Snijdelaar D.G., Dirksen R., Slappendel R., and Crul B.J.P. Substance P. Eur J Pain 4 (2000) 121-135
37. Toresson G., Brodin E., Wahlstroem A., and Bertilsson L. Detection of N-terminally extended substance P but not of substance P in human cerebrospinal fluid: quantitation with HPLC-radioimmunoassay. J Neurochem 50 (1988) 1701-1707
38. Toresson G., Brodin E., and Bertilsson L. N-terminally extended tachykinins in human cerebrospinal fluid. Regul Pept 46 (1993) 357-359
39. Toresson G., Brodin E., de las Carreras C., Nordin C., Zachau A.C., and Bertilsson L. Quantitation of N-terminally extended tachykinins in cerebrospinal fluid from healthy subjects. Regul Pept 50 (1994) 185-191
40. Tumani H., Nau R., and Felgenhauer K. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 44 (1998) 882-889
41. White D.M. Release of substance P from peripheral sensory nerve terminals. J Periph Nervous Syst 2 (1997) 191-201
42. Zubrzycka M., and Janecka A. Substance P: transmitter of nociception. Endocrine Regul 34 (2000) 195-201